Biomerica (BMRA) Capital Expenditures Growth (3y) (2013 - 2024)
Biomerica (BMRA) Capital Expenditures Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 9.52% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -6.22% |
| Nov 30, 2023 | -35.13% |
| Aug 31, 2023 | -19.05% |
| Feb 28, 2023 | -34.55% |
| Nov 30, 2022 | 79.47% |
| Aug 31, 2022 | 150.19% |
| May 31, 2022 | -4.63% |
| Feb 28, 2022 | -10.31% |
| Nov 30, 2021 | -4.48% |
| Aug 31, 2021 | -48.70% |
| May 31, 2021 | -19.63% |
| Feb 28, 2021 | 28.34% |
| Nov 30, 2020 | -12.63% |
| Aug 31, 2020 | 25.61% |
| May 31, 2020 | 185.82% |
| Feb 29, 2020 | -32.68% |
| May 31, 2019 | 9.35% |
| Feb 28, 2019 | -21.90% |
| Nov 30, 2018 | -12.79% |
| Aug 31, 2018 | 88.56% |